Comparison of simplexa universal direct PCR with cytotoxicity assay for diagnosis of clostridium difficile infection: Performance, cost, and correlation with disease

Journal of Clinical Microbiology

Volumn 52, Issue 1, 2014, Pages 275-280

  Landry, Marie L ^a,b,c   Ferguson, David ^c   Topal, Jeffrey ^b  

^a Internal Medicine   (United States)

^b General Internal Medicine   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM ISOLATION; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COST BENEFIT ANALYSIS; CYTOTOXICITY ASSAY; FALSE POSITIVE RESULT; FECES ANALYSIS; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIMPLEXA CLOSTRIDIUM DIFFICILE UNIVERSAL DIRECT POLYMERASE CHAIN REACTION; TCDB GENE; VALIDITY;

BACTERIAL PROTEINS; BACTERIAL TOXINS; BIOLOGICAL ASSAY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; GLUTAMATE DEHYDROGENASE; HUMANS; NEUTRALIZATION TESTS; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84891447317     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02545-13     Document Type: Article

References (28)

1. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH, Society for Healthcare Epidemiology of America, Infectious Diseases Society of America. 2010. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect. Control Hosp. Epidemiol. 31:431-455. http://dx.doi.org/10.1086/651706.
2. Burnham CA, Carroll KC. 2013. Diagnosis of Clostridium difficile infection: An ongoing conundrum for clinicians and for clinical laboratories. Clin. Microbiol. Rev. 26:604-630. http://dx.doi.org/10.1128/CMR.00016-13.
3. Kvach EJ, Ferguson D, Riska PF, Landry ML. 2010. Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection. J. Clin. Microbiol. 48:109-114. http://dx.doi.org/10.1128/ JCM.01630-09.
4. Barbut F, Braun M, Burghoffer B, Lalande V, Eckert C. 2009. Rapid detection of toxigenic strains of Clostridium difficile in diarrheal stools by real-time PCR. J. Clin. Microbiol. 47:1276-1277. http://dx.doi.org/10.1128/JCM. 00309-09.
5. Stamper PD, Alcabasa R, Aird D, Babiker W, Wehrlin J, Ikpeama I, Carroll KC. 2009. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J. Clin. Microbiol. 47:373-378. http://dx.doi.org/10.1128/JCM .01613-08.
6. Wilcox MH. 2012. Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection. Clin. Microbiol. Infect. 18(Suppl. 6):13-20. http://dx.doi.org/10.1111/1469-0691.12057.
7. Shetty N, Wren MW, Coen PG. 2011. The role of glutamate dehydrogenase for the detection of Clostridium difficile in faecal samples: A metaanalysis. J. Hosp. Infect. 77:1-6. http://dx.doi.org/10.1016/j.jhin.2010.07 .024.
8. Carman RJ, Wickham KN, Chen L, Lawrence AM, Boone JH, Wilkins TD, Kerkering TM, Lyerly DM. 2012. Glutamate dehydrogenase is highly conserved among Clostridium difficile ribotypes. J. Clin. Microbiol. 50: 1425-1426. http://dx.doi.org/10.1128/JCM.05600-11.
9. Rupnik M, Braun V, Soehn F, Janc M, Hofstetter M, Laufenberg-Feldmann R, von Eichel-Streiber C. 1997. Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile. FEMS Microbiol. Lett. 148:197-202. http://dx.doi.org/10.1111/j.1574-6968 .1997.tb10288.x.
10. Cohen SH, Tang YJ, Silva J, Jr. 2000. Analysis of the pathogenicity locus in Clostridium difficile strains. J. Infect. Dis. 181:659-663. http://dx.doi.org/10.1086/315248.
11. Longtin Y, Trottier S, Brochu G, Paquet-Bolduc B, Garenc C, Loungnarath V, Beaulieu C, Goulet D, Longtin J. 2013. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin. Infect. Dis. 56:67-73. http://dx.doi.org/10.1093/cid/ cis840.
12. Sethi AK, Al-Nassir WN, Nerandzic MM, Bobulsky GS, Donskey CJ. 2010. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect. Control Hosp. Epidemiol. 31:21-27. http://dx.doi.org/10.1086/649016.
13. Dubberke ER, Han Z, Bobo L, Hink T, Lawrence B, Copper S, Hoppe-Bauer J, Burnham CA, Dunne WM, Jr. 2011. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J. Clin. Microbiol. 49:2887-2893. http://dx.doi.org/10.1128/JCM .00891-11.
14. Polage CR, Solnick JV, Cohen SH. 2012. Nosocomial diarrhea: Evaluation and treatment of causes other than Clostridium difficile. Clin. Infect. Dis. 55:982-989. http://dx.doi.org/10.1093/cid/cis551.
15. Ludwig A, Sato K, Schirmer P, Maniar A, Lucero-Obusan C, Fleming C, Ryono R, Oda G, Winters M, Holodniy M. 2013. Concurrent outbreaks with co-infection of norovirus and Clostridium difficile in a long-termcare facility. Epidemiol. Infect. 141:1598-1603. http://dx.doi.org/10.1017/S0950268813000241.
16. Kyne L, Warny M, Qamar A, Kelly CP. 2000. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N. Engl. J.Med. 342:390-397. http://dx.doi.org/10.1056/NEJM200002103420604.
17. Leekha S, Aronhalt KC, Sloan LM, Patel R, Orenstein R. 2013. Asymptomatic Clostridium difficile colonization in a tertiary care hospital: Admission prevalence and risk factors. Am. J. Infect. Control 41:390-393. http://dx.doi.org/10.1016/j.ajic.2012.09.023.
18. Miyajima F, Roberts P, Swale A, Price V, Jones M, Horan M, Beeching N, Brazier J, Parry C, Pendleton N, Pirmohamed M. 2011. Characterisation and carriage ratio of Clostridium difficile strains isolated from a community-dwelling elderly population in the United Kingdom. PLoS One 6:e22804. http://dx.doi.org/10.1371/journal.pone.0022804.
19. Rousseau C, Poilane I, De Pontual L, Maherault AC, Le Monnier A, Collignon A. 2012. Clostridium difficile carriage in healthy infants in the community: A potential reservoir for pathogenic strains. Clin. Infect. Dis. 55:1209-1215. http://dx.doi.org/10.1093/cid/cis637.
20. Lamouse-Smith ES, Weber S, Rossi RF, Neinstedt LJ, Mosammaparast N, Sandora TJ, McAdam AJ, Bousvaros A. 2013. Polymerase chain reaction test for Clostridium difficile toxin B gene reveals similar prevalence rates in children with and without inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 57:293-297. http://dx.doi.org/10.1097/MPG.0b013e3182999990.
21. Guerrero DM, Becker JC, Eckstein EC, Kundrapu S, Deshpande A, Sethi AK, Donskey CJ. 2013. Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients. J. Hosp. Infect. 85:155-158. http://dx.doi.org/10.1016/j. jhin.2013.07.002.
22. Shim JK, Johnson S, Samore MH, Bliss DZ, Gerding DN. 1998. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 351:633-636. http://dx.doi.org/10.1016/S0140- 6736(97)08062-8.
23. Johnson S, Homann SR, Bettin KM, Quick JN, Clabots CR, Peterson LR, Gerding DN. 1992. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial. Ann. Intern. Med. 117:297-302.
24. Planche TD, Davies KA, Coen PG, Finney JM, Monahan IM, Morris KA, O'Connor L, Oakley SJ, Pope CF, Wren MW, Shetty NP, Crook DW, Wilcox MH. 2013. Differences in outcome according to Clostridium difficile testing method: A prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect. Dis. 13:936-945. http://dx.doi.org/10.1016/S1473-3099(13)70200-7.
25. Baker I, Leeming JP, Reynolds R, Ibrahim I, Darley E. 2013. Clinical relevance of a positive molecular test in the diagnosis of Clostridium difficile infection. J. Hosp. Infect. 84:311-315. http://dx.doi.org/10.1016/j .jhin.2013.05.006.
26. Walker AS, Eyre DW, Wyllie DH, Dingle KE, Harding RM, O'Connor L, Griffiths D, Vaughan A, Finney J, Wilcox MH, Crook DW, Peto TE. 2012. Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing. PLoS Med. 9:e1001172. http://dx.doi.org/10.1371/journal.pmed.1001172.
27. Curry SR, Schlackman JL, Pasculle AW, Shutt KA, Marsh JW, Harrison LH. 2013. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin. Infect. Dis. 57:1094-1102. http://dx.doi.org/10.1093/cid/ cit475.
28. Reller ME, Lema CA, Perl TM, Cai M, Ross TL, Speck KA, Carroll KC. 2007. Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J. Clin. Microbiol. 45:3601-3605. http://dx.doi.org/10.1128/JCM.01305-07.